Technical Analysis for AXGT - Axovant Sciences Ltd.

Grade Last Price % Change Price Change
grade F 3.57 -9.85% -0.39
AXGT closed down 9.85 percent on Monday, January 27, 2020, on 1.38 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AXGT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -9.85%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Axovant Sciences is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurological and neuromuscular diseases. The company’s current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), Parkinson’s disease, oculopharyngeal muscular dystrophy (OPMD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.
Rare Diseases Gene Therapy Amyotrophic Lateral Sclerosis Parkinson’s Disease Frontotemporal Dementia Lipid Storage Disorders Oculopharyngeal Muscular Dystrophy Axovant Sciences Gangliosidosis Gm1 Gm1 Gangliosidosis Gm2 Gangliosidoses Gm 2 Gangliosidosis Gm2 Gangliosidosis Neurological And Neuromuscular Diseases Sandhoff Disease Tay Sachs Disease Tay–Sachs Disease

Is AXGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.6
52 Week Low 3.55
Average Volume 186,154
200-Day Moving Average 6.39
50-Day Moving Average 4.99
20-Day Moving Average 4.76
10-Day Moving Average 4.45
Average True Range 0.34
ADX 23.76
+DI 9.53
-DI 33.40
Chandelier Exit (Long, 3 ATRs ) 4.40
Chandelier Exit (Short, 3 ATRs ) 4.58
Upper Bollinger Band 5.63
Lower Bollinger Band 3.89
Percent B (%b) -0.18
BandWidth 36.58
MACD Line -0.33
MACD Signal Line -0.21
MACD Histogram -0.1203
Fundamentals Value
Market Cap 383.86 Million
Num Shares 108 Million
EPS -2.10
Price-to-Earnings (P/E) Ratio -1.70
Price-to-Sales 0.00
Price-to-Book 2.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.17
Resistance 3 (R3) 4.23 4.09 4.07
Resistance 2 (R2) 4.09 3.94 4.06 4.04
Resistance 1 (R1) 3.83 3.84 3.76 3.77 4.00
Pivot Point 3.69 3.69 3.66 3.66 3.69
Support 1 (S1) 3.43 3.54 3.36 3.37 3.14
Support 2 (S2) 3.29 3.44 3.26 3.10
Support 3 (S3) 3.03 3.29 3.07
Support 4 (S4) 2.97